Dr. Salmasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8851 Center Dr
Ste 501
La Mesa, CA 91942Phone+1 619-697-2456Fax+1 858-429-7930
Education & Training
- Clinical and Translational Science Institute, UCLAMSCR, 2016 - 2018
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2011 - 2015
- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2009 - 2011
- Tehran University of Medical Sciences School of MedicineClass of 2004
Certifications & Licensure
- CA State Medical License 2015 - 2026
- NJ State Medical License 2013 - 2017
- American Board of Urology Urology
Publications & Presentations
PubMed
- 186 citationsDetection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingDavid C. Johnson, Steven S. Raman, Sohrab Afshari Mirak, Lorna Kwan, Amirhossein Mohammadian Bajgiran
European Urology. 2019-05-01 - 57 citationsMolecular Hallmarks of Multiparametric Magnetic Resonance Imaging Visibility in Prostate Cancer.Kathleen E. Houlahan, Amirali Salmasi, Taylor Y. Sadun, Aydin Pooli, Ely Felker
European Urology. 2019-07-01 - 29 citationsRole of surgical approach on lymph node dissection yield and survival in patients with upper tract urothelial carcinoma.Andrew T. Lenis, Nicholas M. Donin, Izak Faiena, Amirali Salmasi, David W. Johnson
Urologic Oncology. 2018-01-01
Journal Articles
- Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingSteven S Raman, Sohrab A Mirak, Izak Faiena, Aydin Pooli, Amirali Salmasi, Ely R Felker, European Urology
- Radical Prostatectomy Then and Now: Surgical Overtreatment of Prostate Cancer Is Declining from 2009 to 2016 at a Tertiary Referral CenterAmirali Salmasi, Izak Faiena, Karim Chamie, Urologic Oncology
Authored Content
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
Press Mentions
- Unio Specialty Care: Advancing the Healthcare Paradigm Shift in Urology and Gastroenterology Towards Value-Based CareJuly 29th, 2024
- Medical Moment: Using Blue Light to Identify Bladder CancerJanuary 7th, 2024
- Gene Therapy for Bladder Cancer Enters ClinicsJuly 10th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Society of Urologic Oncology - SUOMember
- San Diego Center for Precision ImmunotherapyMember
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: